Alpha 2.0
Login Register
» Articles » PMID: 34117578

Hepatic Artery Infusion Pump (HAIP) Therapy Versus Chemotherapy in the First-Line Setting for Patients with Unresectable Intrahepatic Cholangiocarcinoma

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2021 Jun 12
PMID 34117578
Citations 2
Authors
Alexander J Rossi
Tahsin M Khan
Allen J Luna
Andrea Cercek
William R Jarnagin
Jonathan M Hernandez
Affiliations
Soon will be listed here.
Citing Articles

Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network.

Judge S, Ghalambor T, Cavnar M, Lidsky M, Merkow R, Cho M Ann Surg Oncol. 2023; 30(12):7362-7370.

PMID: 37702903 PMC: 11108096. DOI: 10.1245/s10434-023-14207-7.

Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network.

Cavnar M, Ghalambor T, Lidsky M, Dominguez-Rosado I, Cho M, Karanicolas P HPB (Oxford). 2022; 24(12):2104-2111.

PMID: 36085262 PMC: 9771984. DOI: 10.1016/j.hpb.2022.08.008.

References
1.
Shroff R, Javle M, Xiao L, Kaseb A, Varadhachary G, Wolff R . Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial. JAMA Oncol. 2019; 5(6):824-830. PMC: 6567834. DOI: 10.1001/jamaoncol.2019.0270. View
2.
Flemming J, Zhang-Salomons J, Nanji S, Booth C . Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: A population-based study. Cancer. 2016; 122(16):2534-43. DOI: 10.1002/cncr.30074. View
3.
ENSMINGER W, Rosowsky A, Raso V, Levin D, Glode M, Come S . A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Res. 1978; 38(11 Pt 1):3784-92. View
4.
Jarnagin W, Schwartz L, Gultekin D, Gonen M, Haviland D, Shia J . Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol. 2009; 20(9):1589-1595. PMC: 2731015. DOI: 10.1093/annonc/mdp029. View
5.
Cercek A, Boerner T, Tan B, Chou J, Gonen M, Boucher T . Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial. JAMA Oncol. 2019; 6(1):60-67. PMC: 6824231. DOI: 10.1001/jamaoncol.2019.3718. View